TED Ted Baker Plc

RNS Number:4225M
Tepnel Life Sciences PLC
24 January 2008



FOR IMMEDIATE RELEASE


                 Tepnel Life Sciences plc ('Tepnel' or 'the Company')

                               Board appointment



Manchester, U.K, 24 January 2008 Tepnel Life Sciences plc (AIM: TED), the
international Molecular Diagnostics and Research Products & Services group, is
pleased to announce the appointment of Michael Keith Slater, aged 33, as Group
Finance Director.


Mr. Slater, ACA, joined Tepnel Life Sciences plc in October 2005 as Group
Financial Controller and has been responsible for the financial and accounting
affairs of Tepnel since appointment. Prior to joining Tepnel, Mr Slater was a
Senior Manager with KPMG, the international accountancy and professional
services firm.


Ben Matzilevich, Tepnel's Chief Executive Officer commented 'On behalf of the
Board of Directors I welcome Michael's appointment to the Board as Group Finance
Director and am confident of his continued success in this position.'


                                     -Ends-



For further information:

Tepnel Life Sciences plc
Ben Matzilevich, CEO
Carol Smith
Tel: 0161 946 2200


Capital MS&L
Mary Clark or Catie Corcoran
Tel: +44 20 7307 5330


Seymour Pierce Limited
Mark Percy
Tel: +44 20 7107 8000


There are no further details required to be disclosed pursuant to schedule 2(g)
of the AIM Rules.

Notes to Editors:


About Tepnel Life Sciences plc - Tepnel Life Sciences plc (AIM: TED) is a
UK-based international life sciences products and services group with two
divisions, Molecular Diagnostics and Research Products & Services.  The Company
has laboratories, manufacturing and operations in the USA, UK and France with
195 employees.



Tepnel provides test kits, reagents and services to two highly synergistic
markets, these being Molecular Diagnostics and Biomedical Research.



The Company's strategy has been to identify high growth niche opportunities
within these multi-billion pound markets.  Tepnel focuses on these opportunities
with internally developed products, patents, expertise and know-how as well as
strategic acquisitions, to develop a leadership position within these defined
market segments.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

BOAFGGZMNFKGRZM

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024